Jeffrey Sarver
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 7
-
- Drug Transport and Resistance Mechanisms 3
- Cancer Treatment and Pharmacology 3
-
- Analytical Chemistry and Chromatography 4
-
- Pancreatic function and diabetes 4
-
- Adipose Tissue and Metabolism 3
-
- Synthesis and biological activity 2
-
- Diabetes Management and Research 2
- Co-authors
- Paul ErhardtWieslaw A. KliśMugunthu R. DhananjeyanKenneth BachmannHoward Y. AndoK BachmannChristopher TrabbicPéter Nagy
- Cited by
- PharmacologyOncologyToxicology
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Jeffrey Sarver
34 papers receiving 519 citations
Peers
Comparison fields: 5 of 109
- Pharmacology 53
- Oncology 102
- Toxicology 11
- Molecular Biology 204
- Spectroscopy 47
Countries citing papers authored by Jeffrey Sarver
This map shows the geographic impact of Jeffrey Sarver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Sarver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Sarver more than expected).
Fields of papers citing papers by Jeffrey Sarver
This network shows the impact of papers produced by Jeffrey Sarver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Sarver. The network helps show where Jeffrey Sarver may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeffrey Sarver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 6 | |
| 2 | 2021 | 2 | |
| 3 | 2020 | 5 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 70 | |
| 6 | 2019 | 45 | |
| 7 | 2018 | 13 | |
| 8 | 2010 | 6 | |
| 9 | 2008 | 14 | |
| 10 | 2008 | 8 | |
| 11 | 2006 | 21 | |
| 12 | 2006 | 27 | |
| 13 | 2006 | 34 | |
| 14 | 2003 | 12 | |
| 15 | 2002 | 6 | |
| 16 | 2002 | 1 | |
| 17 | 1997 | 25 | |
| 18 | 1996 | 25 | |
| 19 | 1991 | 5 | |
| 20 | 1990 | 10 |
About Jeffrey Sarver
Jeffrey Sarver is a scholar working on Pharmacology, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 34 papers that have together received 529 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Analytical Chemistry and Chromatography (4 papers), Pancreatic function and diabetes (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Cancer Treatment and Pharmacology (3 papers), Adipose Tissue and Metabolism (3 papers), Synthesis and biological activity (2 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Pharmacology (53 citations), Oncology (102 citations) and Toxicology (11 citations). Jeffrey Sarver has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Paul Erhardt, Wieslaw A. Kliś, Mugunthu R. Dhananjeyan, Kenneth Bachmann, Howard Y. Ando, K Bachmann, Christopher Trabbic, Péter Nagy, William A. Maltese and Ronald L. Fournier.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.